Toronto Stocks Edge Forward; Shares of Altius Minerals Rise on 4Q Revenue Beat
By Adriano Marchese
Toronto-listed stocks inched higher on Tuesday as investors digest the latest U.S. inflation data, which showed a slightly hotter-than-expected increase of 3.2%.
Canada's S&P/TSX Composite Index was up 0.22% at 21816.79 and the blue-chip S&P/TSX 60 rose by 0.30% to 1317.79.
Sector performance was mixed in the session, with tech the major gainer, followed by health services and consumer discretionary. Utilities were down the most followed by materials and producer manufacturing stocks.
Shares of Altius Minerals rose 7.3% to 20.57 Canadian dollars ($15.25) after reporting late Monday that royalty revenue came in lower, but better than expected, in the fourth quarter. The company also said it expects growth to improve thanks to new developments in its portfolio.
Other market movers:
Eupraxia Pharmaceuticals' stock fell 30% to C$4.12 after the biotechnology company priced a C$30 million share offering
Shares of STEP Energy Services fell 16% to C$3.60 after the company swung to a fourth-quarter loss as margins were squeezed by a decline in pricing and a decline in fracturing activity.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
March 12, 2024 12:31 ET (16:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk